Logo image of FCLI.CA

FULL CIRCLE LITHIUM CORP (FCLI.CA) Stock Fundamental Analysis

TSX-V:FCLI - TSX Venture Exchange - CA3599171012 - Common Stock - Currency: CAD

0.22  -0.01 (-4.35%)

Fundamental Rating

3

FCLI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for FCLI as it has an excellent financial health rating, but there are worries on the profitability. FCLI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

FCLI had negative earnings in the past year.
FCLI had a negative operating cash flow in the past year.
FCLI.CA Yearly Net Income VS EBIT VS OCF VS FCFFCLI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

FCLI has a Return On Assets of -52.86%. This is comparable to the rest of the industry: FCLI outperforms 46.67% of its industry peers.
Looking at the Return On Equity, with a value of -57.60%, FCLI is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
ROA -52.86%
ROE -57.6%
ROIC N/A
ROA(3y)-44.05%
ROA(5y)N/A
ROE(3y)-49.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FCLI.CA Yearly ROA, ROE, ROICFCLI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

FCLI has a Gross Margin of 61.20%. This is amongst the best in the industry. FCLI outperforms 100.00% of its industry peers.
The Profit Margin and Operating Margin are not available for FCLI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FCLI.CA Yearly Profit, Operating, Gross MarginsFCLI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

8

2. Health

2.1 Basic Checks

FCLI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FCLI has more shares outstanding
There is no outstanding debt for FCLI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FCLI.CA Yearly Shares OutstandingFCLI.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M
FCLI.CA Yearly Total Debt VS Total AssetsFCLI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

FCLI has an Altman-Z score of 14.13. This indicates that FCLI is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 14.13, FCLI is doing good in the industry, outperforming 80.00% of the companies in the same industry.
FCLI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.13
ROIC/WACCN/A
WACC7.89%
FCLI.CA Yearly LT Debt VS Equity VS FCFFCLI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 2.34 indicates that FCLI has no problem at all paying its short term obligations.
The Current ratio of FCLI (2.34) is better than 73.33% of its industry peers.
A Quick Ratio of 2.19 indicates that FCLI has no problem at all paying its short term obligations.
FCLI has a Quick ratio of 2.19. This is in the better half of the industry: FCLI outperforms 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.19
FCLI.CA Yearly Current Assets VS Current LiabilitesFCLI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

FCLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.04%, which is quite impressive.
EPS 1Y (TTM)39.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 79.22% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2Y79.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FCLI.CA Yearly Revenue VS EstimatesFCLI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M
FCLI.CA Yearly EPS VS EstimatesFCLI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2026 0 0.02 -0.02 0.04 -0.04 0.06 -0.06

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

FCLI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 2.64, the valuation of FCLI can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FCLI indicates a rather cheap valuation: FCLI is cheaper than 93.33% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.04. FCLI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 2.64
FCLI.CA Price Earnings VS Forward Price EarningsFCLI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FCLI.CA Per share dataFCLI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06 0.08

4.3 Compensation for Growth

FCLI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FCLI's earnings are expected to grow with 79.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.22%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FCLI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FULL CIRCLE LITHIUM CORP

TSX-V:FCLI (8/8/2025, 7:00:00 PM)

0.22

-0.01 (-4.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)06-27 2025-06-27/amc
Earnings (Next)09-26 2025-09-26
Inst Owners5.64%
Inst Owner ChangeN/A
Ins Owners20.43%
Ins Owner ChangeN/A
Market Cap16.70M
Analysts84
Price Target1.53 (595.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.99%
Min EPS beat(2)0.99%
Max EPS beat(2)0.99%
EPS beat(4)4
Avg EPS beat(4)0.99%
Min EPS beat(4)0.99%
Max EPS beat(4)0.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-85%
Revenue NY rev (3m)-85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.64
P/S 20.26
P/FCF N/A
P/OCF N/A
P/B 2.63
P/tB 2.82
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0.08
Fwd EY37.84%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.01
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.86%
ROE -57.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.2%
FCFM N/A
ROA(3y)-44.05%
ROA(5y)N/A
ROE(3y)-49.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 217.56%
Cap/Sales 103.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 2.19
Altman-Z 14.13
F-Score6
WACC7.89%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y100%
EPS Next 2Y79.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.69%
OCF growth 3YN/A
OCF growth 5YN/A